Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
May 16, 2022
Subverting the immunoproteasome in acute myeloid leukemia
From the Chapuis and Greenberg Labs, Clinical Research Division
WT1 T-cell Receptor Transduced T cells prevent AML relapse
From the Chapuis and Greenberg Labs, Clinical Research Division
Eight promising projects win Evergreen Fund grants to promote commercialization of research
A dozen scientists to receive up to $200K from 3-year-old Fred Hutch program
Molecular mechanisms of late cancer relapse
from the Chapuis lab, Clinical Research Division
New guide helps clinicians navigate immunotherapy revolution in Merkel cell carcinoma
‘Real-world’ review accompanies new clinical care guidelines in rare skin cancer
The rare make the most
from the Chapuis lab (Clinical Research Division)